Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

HSBC, stronger pound pressure FTSE 100; Greggs outshines mid-caps

Published 19/02/2019, 17:18
Updated 19/02/2019, 17:18
© Reuters. Pedestrians leave and enter the London Stock Exchange in London

© Reuters. Pedestrians leave and enter the London Stock Exchange in London

By Shashwat Awasthi and Muvija M

(Reuters) - Britain's main index fell on Tuesday, weighed down by disappointing results from blue-chip heavyweight HSBC and a stronger pound, while mid-cap baker Greggs surged to a record high after guiding to higher full-year profits.

The FTSE 100 closed down 0.6 percent, its biggest fall in nearly two weeks, and the FTSE 250 was down 0.3 percent.

HSBC was the biggest drag on the main bourse on its worst day in almost two years, as uncertainty around the China-U.S. trade situation was reflected in the Asia-focused bank's disappointing profit growth.

Its shares slipped 4 percent, knocking more than 20 points off the FTSE 100 and dragging peer Standard Chartered (LON:STAN) down 2.1 percent, with the bank warning weaker economic outlooks for China and Britain would pose more challenges this year.

Spreadex analyst Connor Campbell said HSBC finds itself "stuck in the middle of a Venn diagram covering China's slowing economy, the concerns surrounding global trade and Britain's Brexit mess."

Sterling rose on hopes that Prime Minister Theresa May's Brexit talks in Brussels this week would yield progress, while relatively strong labour market data helped sentiment towards the currency.

Reckitt Benckiser fell 2.3 percent while other major dollar earners including AstraZeneca and Unilever (LON:ULVR) also gave up a percent each.

A new round of China-U.S. trade negotiations kicks off this week and reports of progress in the talks, despite a lack of clear details, have raised hopes that the countries can reach a compromise by a March 1 deadline.

High street baker Greggs jumped 11.2 percent to an all-time high on the mid-cap index as sales rose in the first seven weeks of 2019 and it forecast higher full-year underlying pretax profit.

But Indivior tumbled 11 percent after the U.S. Supreme Court rejected the drugmaker's bid to block Dr. Reddy's Laboratories' copycat of its lucrative opioid addiction treatment Suboxone Film.

Online trading platform Plus500 (LON:PLUSP), which has slumped since last week after a profit warning and a drafting error in its 2017 report, fell for a seventh straight session. The stock was down 10.7 percent.

© Reuters. Pedestrians leave and enter the London Stock Exchange in London

Engineering firm Cobham (LON:COB) advanced 4.9 percent after agreeing to settle a dispute with Boeing (NYSE:BA) over its delayed KC-46 aerial refuelling programme.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.